Senior insider sale
Chief Financial Officer at VIKING THERAPEUTICS, INC. — senior position signals high conviction
$922.2K
16.14K shares
What this filing means
ZANTE GREG plans to sell 16.14K shares of VIKING THERAPEUTICS, INC. valued at approximately $922.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/30/2024ACC: 0001950047-24-005692
Officer· Chief Financial Officer
Since Jan 2021
16.14K
Shares to sell
$922.2K
Approx. market value
16.14K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Performance Stock Units
Services Rendered
7/29/2024
16.14KTotal acquired16.14K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/29/2024 | Performance Stock Units Services Rendered | 16.14K | — |
| Total | 16.14K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
16.14K
Market value
$922.2K
7/30/2024
Total
Units
16.14K
Value
$922.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
7/30/2024 | 16.14K | $922.2K | NASDAQ | Planned |
| Total | 16.14K | $922.2K | ||